EUCTR2004-001056-36-ES进行中（未招募）不适用
Ensayo clínico con Ziprasidona para el tratamiento de la psicopatología no constituyente de un trastorno mental grave en la dependencia del alcohol - Ensayo con ziprasidona para el tratamiento de la paqtología psiquiátrica asociada al alcoholismo
Institut de Recerca0 个研究点目标入组 60 人开始时间: 2004年6月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Alcoholismo
- •2. 18 a 65 años de edad
- •3. Puntuación igual o superior a 7 en la escala GHQ-28
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Trastortornos orgánicos graves
- •2. Trastorno psicótico o bipolar gravemente descompensado que requiera tratamiento antipsicótico
- •3. Mujeres embarazadas o lactantes
研究者
相似试验
终止
3 期
A Pilot Study - Ziprasidone used as an Adjunctive Therapy in patients with Major Depressive Disorder: Impact on Symptoms and Functional DisabilityMental Health - DepressionMajor Depressive DisorderACTRN12607000571471Dr Nitin Dharwadkar15
进行中（未招募）
1 期
Study to compare the efficacy of ziprasidone (Zeldox) and aripiprazole (Abilify) on cognitive functioning and quality of sleep in the treatment of schizophrenic patientsSchizophreniaEUCTR2005-004501-28-DEDepartment of Psychiatry, Ludwig-Maximilians-University Munich60
终止
3 期
Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I DisorderBipolar DisorderNCT02075047Pfizer's Upjohn has merged with Mylan to form Viatris Inc.171
终止
3 期
Safety And Efficacy Of Ziprasidone In Adolescents With SchizophreniaSchizophreniaNCT00257192Pfizer's Upjohn has merged with Mylan to form Viatris Inc.284
已完成
3 期
Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)Bipolar DisorderNCT00257166Pfizer's Upjohn has merged with Mylan to form Viatris Inc.238